Back to Search
Start Over
Mitochondrial calcium uniporter blocker effectively prevents brain mitochondrial dysfunction caused by iron overload.
- Source :
-
Life sciences [Life Sci] 2013 Mar 12; Vol. 92 (4-5), pp. 298-304. Date of Electronic Publication: 2013 Jan 16. - Publication Year :
- 2013
-
Abstract
- Aims: Although iron overload induces oxidative stress and brain mitochondrial dysfunction, and is associated with neurodegenerative diseases, brain mitochondrial iron uptake has not been investigated. We determined the role of mitochondrial calcium uniporter (MCU) in brain mitochondria as a major route for iron entry. We hypothesized that iron overload causes brain mitochondrial dysfunction, and that the MCU blocker prevents iron entry into mitochondria, thus attenuating mitochondrial dysfunction.<br />Main Methods: Isolated brain mitochondria from male Wistar rats were used. Iron (Fe(2+) and Fe(3+)) at 0-286 μM were applied onto mitochondria at various incubation times (5-30 min), and the mitochondrial function was determined. Effects of MCU blocker (Ru-360) and iron chelator were studied.<br />Key Findings: Both Fe(2+) and Fe(3+) entered brain mitochondria and caused mitochondrial swelling in a dose- and time-dependent manner, and caused mitochondrial depolarization and increased ROS production. However, Fe(2+) caused more severe mitochondrial dysfunction than Fe(3+). Although all drugs attenuated mitochondrial dysfunction caused by iron overload, only an MCU blocker could completely prevent ROS production and mitochondrial depolarization.<br />Significance: Our findings indicated that iron overload caused brain mitochondrial dysfunction, and that an MCU blocker effectively prevented this impairment, suggesting that MCU could be the major portal for brain mitochondrial iron uptake.<br /> (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Brain metabolism
Brain ultrastructure
Citrates pharmacology
Dose-Response Relationship, Drug
Ferric Compounds pharmacology
Ferrous Compounds pharmacology
In Vitro Techniques
Iron Chelating Agents pharmacology
Iron Overload complications
Iron Overload pathology
Male
Membrane Potential, Mitochondrial drug effects
Microscopy, Electron, Transmission
Mitochondria metabolism
Mitochondria ultrastructure
Mitochondrial Swelling drug effects
Quaternary Ammonium Compounds pharmacology
Rats
Rats, Wistar
Reactive Oxygen Species metabolism
Time Factors
Brain drug effects
Calcium Channels metabolism
Iron Overload metabolism
Mitochondria drug effects
Ruthenium Compounds pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0631
- Volume :
- 92
- Issue :
- 4-5
- Database :
- MEDLINE
- Journal :
- Life sciences
- Publication Type :
- Academic Journal
- Accession number :
- 23333832
- Full Text :
- https://doi.org/10.1016/j.lfs.2013.01.004